Results of CPX-351 vs 7+3. (A) EFS of secondary AML patients. (B) OS of secondary AML patients. See the complete Figure 1 in the article by Lancet et al that begins on page 3239.

Results of CPX-351 vs 7+3. (A) EFS of secondary AML patients. (B) OS of secondary AML patients. See the complete Figure 1 in the article by Lancet et al that begins on page 3239.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal